• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Humana to reward Allscripts electronic health record adoption

Article

Humana Inc. has formed an alliance with Allscripts to provide eligible physician practices with incentives for implementing electronic health record (EHR) technology.

Humana Inc. has formed an alliance with Allscripts to provide eligible physician practices with incentives for implementing electronic health record (EHR) technology.

Humana will provide financial assistance to selected physicians for adoption of the Allscripts EHR as part of Humana’s Medical Home EHR Rewards Program. Physician practices that participate will receive clinical information electronically at the point of care. Humana will financially reward primary care physicians for improved clinical performance.

Through Humana’s Medical Home EHR Rewards Program, physician encounters are measured in conjunction with HEDIS quality measures.

Humana already delivers health information and clinical messaging about its members through the Availity Health Information Network. This information is available to physicians online via the Availity CareProfile, a longitudinal patient record that includes care provided by multiple treating physicians and facilities. Going forward, CareProfile information will be integrated with participating EHR vendor systems and presented at the point of care, seamlessly integrating with the physician workflow.

Through their work with Humana and Allscripts, physician practices will be provided with individualized goals and regular feedback on clinical and other performance. They may also be eligible to receive additional financial benefits but only after the practices meet or exceed certain quality benchmarks.

Related Videos
Video 3 - "In-Office Procedures, Over-the-Counter Options, Treatment Delays, and Costs"
Video 6 - "Safety Analysis and Interpreting Results from MAJIC-PV"
Video 5 - "Key Findings from MAJIC-PV"
Video 2 - "Traditional Treatment of Demodex Blepharitis, FDA approval, and Lotilaner Ophthalmic Solution, 0.25%"
Gabriela Hobbs, MD, an expert on polycythemia vera
Gabriela Hobbs, MD, and Timothy Mok, PharmD, BCPS, BCOP
Video 1 - "Demodex Blepharitis: Prevalence, Symptoms, Quality of Life Impact, and Diagnosis"
Video 2 - "The Role of Ruxolitinib in Managing Hydroxyurea Resistance or Intolerance"
Video 1 - "Prevalence and Impact of Hydroxyurea Intolerance or Resistance in Polycythemia Vera"
Related Content
© 2024 MJH Life Sciences

All rights reserved.